Novel glycerol cyclic pyruvate derivates were prepared and demonstrated to inhibit the binding of an immobilized D-proline derivative to serum amyloid P component (SAP) have been prepared. As such, the compounds of the invention are useful for treating amyloidosis and diseases associated with amyloidosis, for example Alzheimer's disease and maturity onset diabetes mellitus.
新型
甘油环状
丙酮衍
生物已经制备并证明能够抑制固定化
D-脯氨酸衍
生物与血清淀粉样蛋白P成分(
SAP)的结合。因此,本发明的化合物可用于治疗淀粉样变性和与淀粉样变性相关的疾病,例如阿尔茨海默病和成人发病型糖尿病。